Lexology July 29, 2024
Taft Stettinius & Hollister LLP

On June 28, 2024, the Supreme Court of the United States overruled longstanding “Chevron deference” in Loper Bright Enterprises v. Raimondo, 603 U.S. ___, No. 22-45 (2024) and Relentless, Inc. v. Department of Commerce No. 22-1219, changing the way courts will review disputes involving interpretation of statutes and agency rules. While much has now changed, the true effects of these rulings in the health care industry will be seen as courts begin issuing decisions to resolve disputes arising from conflicting interpretations of health care statutes — such as the interpretation by the Centers for Medicare and Medicaid Services (CMS) — without deference to the agency.

This law bulletin summarizes Chevron, the new Supreme Court ruling, and implications for the health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
OpenAI, Australia and EU Each Push Own AI Regulations
What The Election Means For Federal Health Care Legislation
A ‘lamer-than-usual’ lame duck?
The European Union AI Act: Time to start preparing

Share This Article